Pieris Pharmaceuticals to Host Conference Call on Strategic Alliance With AstraZeneca
BOSTON, MA--(Marketwired - May 03, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), today announced a strategic collaboration in respiratory disease with AstraZeneca to develop novel inhaled biologics that leverage Pieris' Anticalin® platform, led …